Industry

Medscape Interview Highlights MediPines AGM100’s 99% Accuracy for Emergency Room Oxygen Therapy Decisions in COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–#COVID–In a video interview on “Hot Topics in Emergency Medicine” posted by Medscape, a group of emergency medicine experts and respiratory physiology thought leaders discussed a new non-invasive measurement; Oxygen Deficit, obtained from the MediPines AGM100, which demonstrated 99% clinical accuracy for supplemental oxygen therapy decisions. The interview was moderated by Robert … [Read more…]

Japan Biotech Startups Directory 2021-2022: Profiles of 395 Companies with Outstanding Technologies and Business Models – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The Directory of Biotech Startups in Japan 2021-2022” directory has been added to ResearchAndMarkets.com’s offering. This report is a directory of startups in the biotech sector in Japan. There are approximately 1,200 startups active in the biotech sector in Japan. The publisher (the most influential media outlet in the Japanese biotech industry since … [Read more…]

GeNeuro : Two Studies on ALS Published in Annals of Neurology Demonstrate the Neurotoxic Role of Human Endogenous Retrovirus Envelope Protein (HERV-K/HML-2 ENV) and the Rationale for Targeted Therapy With Specific Antibody

The first publication confirms the neurotoxic role of HERV-K/HML-2 ENV detected in the cerebrospinal fluid of sporadic ALS patients and the preclinical therapeutic effect of GeNeuro’s anti-HERV-K ENV antibody in neutralizing HERV-K/HML-2 ENV toxicity. The second publication provides a clinically based rationale for the therapeutic use of a specific neutralizing antibody addressing sporadic ALS neuropathology, … [Read more…]

Orthopedic Braces & Support, Casting and Splints Global Market Report 2022: Increased Sports Activities Driving Injury Rates and Fueling Demand – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Braces & Support, Casting and Splints – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Orthopedic Braces & Support, Casting and Splints Market to Reach US$7.8 Billion by the Year 2026 The market is witnessing an increased demand from the geriatric population, which is very sensitive in … [Read more…]

Global Topical Drugs Market (2022 to 2030) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Topical Drugs Market Size, Share & Trends Analysis Report by Type (Semi-solid, Liquid), by Route Of Administration (Dermal, Ophthalmic), by End-use (Burn Centers, Hospitals & Clinics), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global topical drugs market size is expected to reach USD 217.79 billion … [Read more…]

AscellaHealth Family of Companies is Founding Sponsor of Inaugural Gene Therapy and Specialty Pharmacy Awareness Month, September 2022

BERWYN, Pa.–(BUSINESS WIRE)–The AscellaHealth Family of Companies, including AscellaHealth, a global healthcare and specialty pharmacy solutions company, and subsidiaries Optime Care and Terebellum, announces its founding sponsorship of the inaugural Gene Therapy and Specialty Pharmacy Awareness Month, September 2022, which was accepted for inclusion in the annual Calendar of Health Observances & Recognition Days, published … [Read more…]

Long COVID Outpaces Diabetes in 2022 Employer Health Care Costs, Nomi Health Research Finds

Diagnoses on the rise as U.S. employers see sharp medical spend increases OREM, Utah–(BUSINESS WIRE)–As COVID-19 cases continue gripping the country, skyrocketing medical costs as a result of long COVID pose a significant financial risk not just for patients, but also for buyers of care in the public and private sectors. According to results of … [Read more…]

HighTide Therapeutics Announces Early Completion of Enrollment in Phase 2 Clinical Study Evaluating HTD1801 in Type 2 Diabetes Mellitus

SHENZHEN, China & ROCKVILLE, Md.–(BUSINESS WIRE)–HighTide Therapeutics, Inc. (“HighTide”), a globally integrated clinical-stage biotechnology company focused on the development of innovative multi-functional therapeutics to address the complex pathophysiology of metabolic and digestive diseases, announced that enrollment was completed ahead of schedule in a Phase 2 study evaluating HTD1801 in patients with type 2 diabetes mellitus … [Read more…]

Ulcerative Colitis Market Forecasts, Epidemiology & Pipeline Analysis 2022-2027: Focus on 8 Major Markets – United States, France, Germany, Italy, Spain, United Kingdom, China, and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ulcerative Colitis Market Forecast – Epidemiology & Pipeline Analysis 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The ulcerative colitis epidemiology provides insights into the historical and current patient pools and forecasted trends for eight (8MM) major countries. The ulcerative colitis segment covers the historical and forecasted epidemiology data in the US, EU5 … [Read more…]

 Navidea Biopharmaceuticals Announces Closing of its Rights Offering and Second Quarter 2022 Earnings Conference Call and Business Update

 Conference Call to be Held on Thursday, September 8, 2022 at 4:00 p.m. (EDT) DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the closing of its rights offering and the final results thereof. Navidea received aggregate gross … [Read more…]